Viability and apoptosis in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20217)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction | Replicate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Selumetinib | COLO 858 | 1.0000 | uM | 72 | hr | 1227 | 275 | 0.3458 | 0.3419 | 0.2241 | 0.2586 | 2 |
Selumetinib | COLO 858 | 1.0000 | uM | 72 | hr | 1188 | 367 | 0.2982 | 0.3419 | 0.3089 | 0.2586 | 3 |
Selumetinib | COLO 858 | 1.0000 | uM | 72 | hr | 1419 | 331 | 0.3952 | 0.3419 | 0.2333 | 0.2586 | 4 |
Selumetinib | COLO 858 | 3.1600 | uM | 24 | hr | 3827 | 528 | 1.1020 | 0.8558 | 0.1380 | 0.1486 | 1 |
Selumetinib | COLO 858 | 3.1600 | uM | 24 | hr | 3852 | 632 | 1.0756 | 0.8558 | 0.1641 | 0.1486 | 2 |
Selumetinib | COLO 858 | 3.1600 | uM | 24 | hr | 2227 | 337 | 0.6313 | 0.8558 | 0.1513 | 0.1486 | 3 |
Selumetinib | COLO 858 | 3.1600 | uM | 24 | hr | 2141 | 302 | 0.6143 | 0.8558 | 0.1411 | 0.1486 | 4 |
Selumetinib | COLO 858 | 3.1600 | uM | 48 | hr | 1867 | 476 | 0.3178 | 0.3147 | 0.2550 | 0.3128 | 1 |
Selumetinib | COLO 858 | 3.1600 | uM | 48 | hr | 1935 | 548 | 0.3169 | 0.3147 | 0.2832 | 0.3128 | 2 |
Selumetinib | COLO 858 | 3.1600 | uM | 48 | hr | 2105 | 776 | 0.3037 | 0.3147 | 0.3687 | 0.3128 | 3 |
Selumetinib | COLO 858 | 3.1600 | uM | 48 | hr | 2138 | 736 | 0.3203 | 0.3147 | 0.3443 | 0.3128 | 4 |
Selumetinib | COLO 858 | 3.1600 | uM | 72 | hr | 1251 | 482 | 0.2793 | 0.2801 | 0.3853 | 0.3831 | 1 |
Selumetinib | COLO 858 | 3.1600 | uM | 72 | hr | 1257 | 433 | 0.2993 | 0.2801 | 0.3445 | 0.3831 | 2 |
Selumetinib | COLO 858 | 3.1600 | uM | 72 | hr | 1217 | 526 | 0.2510 | 0.2801 | 0.4322 | 0.3831 | 3 |
Selumetinib | COLO 858 | 3.1600 | uM | 72 | hr | 1271 | 471 | 0.2906 | 0.2801 | 0.3706 | 0.3831 | 4 |
Vemurafenib | COLO 858 | 0.0032 | uM | 24 | hr | 3250 | 162 | 1.0315 | 0.7818 | 0.0498 | 0.0468 | 1 |
Vemurafenib | COLO 858 | 0.0032 | uM | 24 | hr | 3561 | 190 | 1.1260 | 0.7818 | 0.0534 | 0.0468 | 2 |
Vemurafenib | COLO 858 | 0.0032 | uM | 24 | hr | 1406 | 72 | 0.4456 | 0.7818 | 0.0512 | 0.0468 | 3 |
Vemurafenib | COLO 858 | 0.0032 | uM | 24 | hr | 1622 | 53 | 0.5241 | 0.7818 | 0.0327 | 0.0468 | 4 |
Vemurafenib | COLO 858 | 0.0032 | uM | 48 | hr | 4071 | 171 | 0.8911 | 0.9264 | 0.0420 | 0.0487 | 1 |
Vemurafenib | COLO 858 | 0.0032 | uM | 48 | hr | 4509 | 236 | 0.9763 | 0.9264 | 0.0523 | 0.0487 | 2 |
Vemurafenib | COLO 858 | 0.0032 | uM | 48 | hr | 4356 | 183 | 0.9535 | 0.9264 | 0.0420 | 0.0487 | 3 |
Vemurafenib | COLO 858 | 0.0032 | uM | 48 | hr | 4114 | 241 | 0.8849 | 0.9264 | 0.0586 | 0.0487 | 4 |
Vemurafenib | COLO 858 | 0.0032 | uM | 72 | hr | 3740 | 309 | 1.2462 | 1.2088 | 0.0826 | 0.0879 | 1 |
Vemurafenib | COLO 858 | 0.0032 | uM | 72 | hr | 3397 | 295 | 1.1267 | 1.2088 | 0.0868 | 0.0879 | 2 |